Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy

Hypertension

Volumn 46, Issue 5, 2005, Pages 1213-1218

  Perlini, Stefano ^a,d   Palladini, Giuseppina ^a   Ferrero, Ivana ^a,e   Tozzi, Rossana ^a   Fallarini, Silvia ^a   Facoetti, Angelica ^a   Nano, Rosanna ^a   Clari, Francesca ^a   Busca, Giuseppe ^b,c   Fogari, Roberto ^a   Ferrari, Alberto U ^d,e,f  

^a UNIVERSITY OF PAVIA   (Italy)

^b Medicina Generale   (Italy)

^c Dept of Int Med and Therapeutics   (Italy)

^d MAGGIORE HOSPITAL   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f Centro di Fisiologia Clinica e Ipertensione   (Italy)

Author keywords

Collagen; Extracellular matrix; Fibrosis; Heart failure; Hypertrophy; Sympathectomy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; COLLAGEN; DOXAZOSIN; GELATINASE A; MATRIX METALLOPROTEINASE; OXIDOPAMINE; PROPRANOLOL; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ABDOMINAL AORTA; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME DEGRADATION; FIBROBLAST; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HISTOLOGY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHECTOMY; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION; TREATMENT OUTCOME; ZYMOGRAPHY;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; COLLAGEN; DOXAZOSIN; FIBROSIS; HYPERTENSION; LUNG; MALE; MATRIX METALLOPROTEINASE 2; MYOCARDIUM; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHECTOMY, CHEMICAL; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 27444436450     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000185689.65045.4c     Document Type: Article

References (25)

1. Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34:724-728.
2. Floras JS. Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. Acta Physiol Scand. 2003;177: 391-398.
3. Grisk O, Rettig R. Interactions between the sympathetic nervous system and the kidneys in arterial hypertension. Cardiovasc Res. 2004;61: 238-246.
4. Parker JD, Thiessen JJ. Increased endothelin-1 production in patients with chronic heart failure. Am J Physiol (Heart Circ Physiol). 2004;286: H1141-1145.
5. Costoli T, Bartolomucci A, Graiani G, Stilli D, Laviola G, Sgoifo A. Effects of chronic psycho-social stress on cardiac autonomic responsiveness and myocardial structure in mice. Am J Physiol (Heart Circ Physiol). 2004;286:H2133-H2140.
6. Dora GW 2nd. Adrenergic pathways and left ventricular remodeling. J Card Fail. 2002;8(6 Suppl):S370-S373.
7. Ennis IL, Escudero EM, Console GM, Camihort G, Dumm CG, Seidler RW, Camilion de Hurtado MC, Cingolani HE. Regression of isoproterenol-induced cardiac hypertrophy by Na+/H+ exchanger inhibition. Hypertension. 2003;41:1324-1329.
8. Packer M. Current role of beta-adrenergic blockers in the management of chronic heart failure. Am J Med. 2001;110 Suppl 7A:81S-94S.
9. Asai K, Yang GP, Geng YJ, Takagi G, Bishop S, Ishikawa Y, Shannon RP, Wagner TE, Vatner DE, Homey CJ, Vatner SF. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic Gs(alpha) mouse. J Clin Invest. 1999;104:551-558.
10. Masson S, Arosio B, Luvara G, Gagliano N, Fiordaliso F, Santambrogio D, Vergani C, Latini R, Annoni G. Remodelling of cardiac extracellular matrix during beta-adrenergic stimulation: upregulation of SPARC in the myocardium of adult rats. J Mol Cell Cardiol 1998;30:1505-1514.
11. Marano G, Palazzesi S, Fadda A, Vergari A, Ferrari AU. Attenuation of aortic banding-induced cardiac hypertrophy by propranolol is independent of beta-adrenoceptor blockade. J Hypertens. 2002;20:763-769.
12. Marano G, Palazzesi S, Vergari A, Catalane L, Gaudi S, Testa C, Canese R, Carpinelli G, Podo F, Ferrari AU. Inhibition of left ventricular remodelling preserves chamber systolic function in pressure-overloaded mice. Pflugers Arch. 2003;446:429-436.
13. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem. 1951;193:265-275.
14. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem. 1994;218:325-329.
15. Tyagi S, Campbell S, Reddy H, Tjahja E, Voiker D. Matrix metalloproteinase activity and expression in infarcted, noninfarcted, and dilated cardiomyiopathic human hearts. Mol Cell Biochem. 1996;155:13-21.
16. Garvey W. Modified elastic tissue-Masson trichrome stain. Stain Technol. 1984;59:213-216.
17. Lindsey ML, Cannon J, Aikawa M, Schoen FJ, Rabkin E, Lopresti-Morrow L, Crawford J, Black S, Libby P, Mitchell PG, Lee RT. Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation. 2002;105:753-758.
18. Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res. 2002;90:520-530.
19. Yoshimura S, Hashimoto K. Role of endogenous beta-adrenergic mechanism in the pathogenesis of spontaneous myocardial fibrosis in rats. J Exp Med. 1988;155:327-333.
20. Chichester CO, Rodgers RL. Effects of doxazosin on vascular collagen synthesis, arterial pressure and serum lipids in the spontanously hypertensive rat. J Cardiovasc Pharmacol. 1987;10(Suppl 9):S21-S26.
21. Tavernier G, Toumaniantz G, Erfanian M, Heymann MF, Laurent K, Langin D, Gauthier C. beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor. Cardiovasc Res. 2003;59:262-265.
22. Bundkirchen A, Brixius K, Bolck B, Schwinger RH. Bucindolol exerts agonistic activity on the propranolol-insensitive state of β1-adrenoceptors in human myocardium. J Pharmacol Exp Ther. 2002;300:794-801.
23. Ferrari AU, Daffonchio A, Franzelli C, Manda G. Potentiation of the baroreceptor-heart rate reflex by sympathectomy in conscious rats. Hypertension. 1991;18:230-235.
24. Mircoli L, Fedele L, Benetti M, Bolla GB, Radaelli A, Perlini S, Ferrari AU. Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure. Circulation. 2002;106: 866-872.
25. Ciulla MM, Paliotti R, Esposito A, Diez J, Lopez B, Dahlof B, Nicholls MG, Smith RD, Gilles L, Magrini F, Zanchetti A. Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trial. Circulation. 2004;110:552-557.